Intracellular Protein Substrates

Intracellular Protein Substrates is a broad, non-specific term referring to the diverse array of proteins located within the cytoplasm, nucleus, or organelles that serve as targets for enzymatic modification or degradation. These substrates are central to cellular physiology, serving as the downstream effectors in signal transduction cascades, metabolic pathways, and structural frameworks (Alberts B, et al. Molecular Biology of the Cell, 2014). In the context of modern drug discovery, the term is frequently associated with targeted protein degradation (TPD) technologies, such as Proteolysis Targeting Chimeras (PROTACs) and molecular glues, which recruit E3 ubiquitin ligases to specific intracellular protein substrates to induce their ubiquitination and subsequent proteasomal degradation (Mullard A. Nat Rev Drug Discov, 2019; Neklesa TK, et al. Pharmacol Ther, 2017). Because it represents a collective group of thousands of distinct proteins rather than a single therapeutic entity, it is not considered a specific drug target in a canonical sense (Salami J, Crews CM. Science, 2017). Instead, therapeutic intervention typically focuses on a specific member of this class, such as the androgen receptor or BRD4, to achieve selectivity and minimize off-target toxicity (Sun X, et al. Signal Transduct Target Ther, 2019).

Other names

Cytoplasmic protein substratesEndogenous protein substratesIntracellular targetsCellular protein substrates

Modulation of protein stability, activity, or localization through enzymatic modification (e.g., phosphorylation) or targeted proteasomal degradation.